MRTNZ

MRTNZ Investment Office · S&P 500 · The 360 Vantage

CVS · NYSE

CVS Health Corporation

Consumer Staples · Retail-Drug Stores and Proprietary Stores

Reference price$109.34As of Jul 28, 2026
Market capitalization$140B
52-week range$58.99–$110.68
S&P 500 portfolio weight0.21%
Data qualitycomplete

Street view

Analyst targets

Published sell-side aggregation—not an MRTNZ forecast.

Low$92.00-15.9% vs. reference
Average$110.56+1.1% vs. reference
High$123.00+12.5% vs. reference
16 Buy1 Hold0 Sell

Forward calendar

Current earnings expectations

Consensus may change until the company reports.

Expected reportAug 5, 2026Jun 2026
Consensus EPS$1.878 estimates
Expected range$1.79–$1.94Low to high EPS
Dec 2026$7.46Street EPS consensus
Dec 2027$8.39Street EPS consensus
Dec 2028$9.39Street EPS consensus

Reported results

Annual financial snapshot

Fiscal period ended Dec 31, 2025.

MetricCurrentPrior
Revenue+7.8% YoY$402B$373B
Operating income$4.66B$8.52B
Net income$1.77B$4.61B
Operating cash flow$10.64B$9.11B
Capital expenditures($2.83B)($2.78B)

Current context

Related news

Company-linked articles surfaced by Nasdaq.

Zacks

Henry Schein Prepares to Report Q2 Earnings: What's in the Cards?

Zacks

The Zacks Analyst Blog Highlights CVS Health, Cardinal Health, Humana and ACADIA Pharmaceuticals

Zacks

UnitedHealth Pulls Back Post 52-Week High: Healthcare ETFs to Watch

Evidence

Sources & method

Nasdaq quote →Nasdaq summary →Earnings forecast →Annual financials →Official S&P 500-tracking holdings →

Facts, estimates, and scenarios are kept separate. Analyst targets and EPS expectations are third-party estimates, not MRTNZ forecasts. Index weight uses the official IVV portfolio as the denominator. Illustrative research, not investment advice.